GENE ONLINE|News &
Opinion
Blog

oncology pipeline
The Cancer Drugmakers Pulling Ahead—and What They’re Building Next
2026-06-22
Gilead’s $5 Billion Bet Targets Tubulis’ Potential Best-in-Class ADC Platform in Oncology Push
2026-04-07
Moderna 2026 at JPM 2026: Projects $1.9B Revenue and Eyes Vaccine Approvals
2026-01-14
Jazz Pharmaceuticals Announces $1 Billion Acquisition of Chimerix to Advance Brain Cancer Treatment
2025-03-06
LATEST
Takeda R&D President Andy Plump and GV Managing Partner Krishna Yeshwant Announce Retirements
2026-09-12
Shine Spect USA Updates Clinical and Safety Guidelines for Xenon Xe-133 Gas
2026-09-11
Amorepacific Updates Hera Black Cushion Ingredient Disclosures for Ten Foundation Shades
2026-09-11
AvKARE Updates Prescribing Information for Etonogestrel and Ethinyl Estradiol Vaginal Ring
2026-09-11
Record Investor Attendance at NLS Days 2026 Drives Nordic Life Science Dealmaking
2026-09-11
Disc Medicine and Silence Therapeutics Develop Polycythemia Vera Treatments to Compete With Takeda and Protagonist
2026-09-11
Leucine Supplementation Linked to Reduced Lymphoid Malignancy Growth and Improved Survival in Study
2026-09-11
Scroll to Top